This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Antiglomerular basement membrane antibody nephritis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Goodpasture's syndrome is a rare vasculitis characterised by the triad of:

  • glomerulonephritis
  • pulmonary haemorrhage
  • autoantibodies to the glomerular basement membrane (GBM) and alveolar basement membrane (1,2)
    • antibodies bind in a linear pattern to a highly specific epitope of the *3 chain of type IV collagen of alveolar and glomerular basement membranes
    • immunoglobulins are almost exclusively of the IgG subtype (with only rare reports of non-IgG class anti-GBM antibodies)
    • IgM and IgA also may be found together with IgG along the GBM in approximately 10% to 20% of cases
    • anti-GBM antibodies may be found in the circulation by indirect immunoflourescence or radioimmunoassay

Goodpasture's syndrome occurs most frequently in young men and may cause renal failure, haemoptysis with pulmonary infiltrates and dyspnoea.

Reference:

  • (1) A.H. Cohen and R.J. Glassock, Anti-GBM Glomerulonephritis including Goodpasture’s disease. In: C.C. Tisher and B.M. Brenner, Editors, Renal Pathology with Clinical and Functional Correlations ((ed 2) ed.),, Lippincott, Philadelphia, PA (1994), pp. 524–553.
  • (2) Espinosa-Melendez E et al. Goodpasture’s syndrome treated with plasmapheresis. Arch Intern Med 1980;140: 542–543.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.